跳至主要内容
临床试验/NCT04089176
NCT04089176已完成早期 1 期

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnant Women With High Risk Postpartum Hemorrhage: a Randomized Controlled Trial

Rajavithi Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
120
试验地点
1
主要终点
Additional drug use

研究概览

简要总结

Objective: study efficacy of carbtocin versus oxytocin for prevention postpartum hemorrhage in high risk pregnancy who undergo cesarean section

详细描述

Randomized controlled clinical trial. Defined patient in two group. Primary outcome is evaluate additional drug use Secondary outcome is evaluated estimated blood loss, hemoglobin level

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • previous history of postpartum hemorrhage
  • polyhydramnios
  • fetal macrosomia
  • previous cesarean section
  • grand multiparity
  • intramural myoma
  • chorioamnionitis
  • prolonged premature rupture of membrane
  • augmentation of labour

排除标准

  • pregnancy induce hypertension
  • on anticoagulant
  • placenta previa or placenta percreta

研究组 & 干预措施

protocal A

Active Comparator

Carbetocin versus placebo

干预措施: Carbetocin (Drug)

protocal A

Active Comparator

Carbetocin versus placebo

干预措施: oxytocin (Drug)

protocal B

Active Comparator

Oxytocin versus placebo

干预措施: Carbetocin (Drug)

protocal B

Active Comparator

Oxytocin versus placebo

干预措施: oxytocin (Drug)

结局指标

主要结局

Additional drug use

时间窗: during intra-operation

Number of additional drug use after intervention drug

次要结局

  • Side effect(During intra-opeartion and acute post operation period as 24 hours post operation)
  • Estimate blood loss(During intra-opeartion and acute post operation period as 24 hours post operation)
  • Hemoglobin level(Pre-operation and 24 hours post operation)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验